The TFRI-MOHCCN Technology Development Awards provides funding to projects to develop additional profiling technologies that would generate data compatible with precision oncology and could be applied to a section of the MOHCCN Gold Cohort.
When autocomplete results are available use up and down arrows to review and enter to select.
In a first-of-its-kind Canadian clinical trial published in the journal Nature Medicine, a group of researchers that included MOHCCN Clinician-Scientist awardee Dr. Bertrand Routy has found that fecal...
The Marathon of Hope – Québec (MOH-Q) brings together leading scientists and clinicians from hospitals and research centres including the Research Institute of the McGill University Health Centre (RI-...